Unsafe antiplatelet use persists in PCI patients
Contraindicated antiplatelet use is rare but persists in patients undergoing percutaneous coronary intervention, show US study data.
Source: MedWire News - Category: Consumer Health News Tags: Interventional cardiology Source Type: news
More News: Angioplasty | Cardiology | Coronary Angioplasty | Health | Heart | Percutaneous Coronary Intervention | Study